The Department of Health & Human Services has released a final rule that would penalize healthcare providers who interfere with a patient’s access to, exchange or use of their electronic health information.
APEX 2024 Winners Announced: The Rheumatologist Receives 2 Awards of Excellence
FDA Updates Safety & Efficacy Information for Voclosporin
The FDA’s latest label change for voclosporin adds data demonstrating its safety and efficacy, as well as a sustained renal response, in patients with lupus nephritis through three years of treatment.
Rheum for Everyone, Episode 10: Demystifying AI
Hosted by Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS, physician editor, The Rheumatologist Amidst mounting excitement over emerging artificial intelligence tools, Dr. Kumar cautions against the expectation that technology will offer a quick fix to complex, systemic healthcare problems. Go to current issue.
A Stepping Stone or a Headache? 2023 MIPS Value Pathway Survey Findings
A survey of providers following the first year of implementation of the new the MIPS Value Pathway reveals mixed reviews of the specialty-specific reporting pathway, with some recommendations for improvement but an overall positive experience.
Unpacking the Court: An Analysis of Recent Supreme Court Decisions
Two recent Supreme Court decisions, Trump v. United States and Loper Bright Enterprises v. Raimond, have broad implications for administrative authority and regulatory advocacy. Joseph Cantrell, JD, analyzes how these decisions may affect the relative power of the different branches of government.
Invest in RheumPAC Before a Critical Reporting Deadline
Approaching a critical Federal Election Commission reporting deadline on July 15, RheumPAC is just $976 short of its key mid-year fundraising goal.
Take Action to Modernize Prior Authorization & Streamline Access to Care
The reintroduction of the Improving Seniors’ Access to Care Act gives an opportunity to reduce administrative burden and undue delay of patient care imposed by prior authorization in Medicare Advantage plans. Contact your members of Congress today to urge them to pass this vital bill.
The ACR and CHEST Release 2 New ILD Guidelines
Clinicians should not rely on glucocorticoids as a first-line treatment of SARD-ILD in patients with systemic sclerosis, according to a strong recommendation in a new ILD treatment guideline from the ACR and CHEST. The guideline is one of two addressing the screening, monitoring and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs).
ACR Applauds Legislation to Reform Prior Authorization Policies
A new bill, the Improving Seniors’ Timely Access to Care Act, aims to streamline the prior authorization process. “The prior authorization process has become unmanageable for both doctors and patients. Insurer red tape imposes a significant burden on clinicians, leading to unnecessary and unclear delays, or even outright denials of patient care,” says ACR President…
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 816
- Next Page »